The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
LDN Community
Join our community here.
Nutrichem's LDN Book Events with Linda Elsegood (Low dose naltrexone) from LDN Research Trust on Vimeo.
The LDN Book Volume 2 & The Goals of the LDN Research Trust
Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway
Transl Oncol
01 February 2021
https://pubmed.ncbi.nlm.nih.gov/33540155/
Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients
MSN News Science Alert
11 February 2021
https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients
Cancer Cell
16 January 2021
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9
The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice
Gynecol Oncol
30 April 2011
https://pubmed.ncbi.nlm.nih.gov/21531450/
Low-dose naltrexone: tricking the body to heal itself
Exp Biol Med (Maywood)
September 2011
https://www.sciencedaily.com/releases/2011/09/110902133047.htm
Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment
Invest New Drugs
August 2013
https://pubmed.ncbi.nlm.nih.gov/23275062/
Metabolic treatment of cancer: intermediate results of a prospective case series
Anticancer Res
February 2014
https://pubmed.ncbi.nlm.nih.gov/24511042/
Background: The combination of hydroxycitrate and lipoic acid has been demonstrated by several laboratories to be effective in reducing murine cancer growth.
Long-term remission of adenoid cystic tongue carcinoma with low dose naltrexone and vitamin D3--a case report
Oral Health Dent Manag
September 2014
http://oralhealth.ro/volumes/2014/volume-3/Paper662.pdf
Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases
Integr Cancer Ther
December 2009
https://pubmed.ncbi.nlm.nih.gov/20042414/